The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil-Reference-Cited by-同舟云学术

The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil

Published:1975-09 Issue:3-4 Volume:36 Page:303-326
ISSN:0300-9564
Container-title:Journal of Neural Transmission
language:en
Short-container-title:J. Neural Transmission

Author:

Birkmayer W.,Riederer P.,Youdim M. B. H.,Linauer W.

Publisher

Springer Science and Business Media LLC

Subject

Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1007/BF01253131.pdf

Reference54 articles.

1. Anton, A. M., andD. F. Sayre: The distribution of Dopamine and Dopa in various animals and a method for their determination in diverse biological material. J. Pharmacol. Exp. Therap.145, 326 (1964).

2. Barbeau, A.: Dopamine and basal ganglia disease. Arch. Neurol.4, 97?102 (1961).

3. Barbeau, A.: The clinical physiology of side effects in long-term L-Dopa therapy. In: Advances in Neurology, Vol. 5, pp. 347?365. New York: Raven Press. 1974.

4. Bernheimer, H., W. Birkmayer, andO. Hornykiewicz: Verteilung des 5-Hydroxytryptamines (Serotonin) im Gehirn des Menschen und sein Verhalten bei Patienten mit Parkinson-Syndrom. Klin. Wschr.39, 1056 to 1059 (1961).

5. Bernheimer, H., W. Birkmayer, andO. Hornykiewicz: Verhalten der Monoaminoxydase im Gehirn des Menschen nach Therapie mit Monoaminoxydase-Hemmern. Wr. klin. Wschr.74 (33/34), 558?559 (1962).

Cited by 369 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic drug monitoring in Parkinson’s disease;Journal of Neural Transmission;2024-09-03

2. L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin;Journal of Neural Transmission;2023-10-05

3. Catecholamines and Parkinson’s disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview;Journal of Neural Transmission;2023-08-28

4. Parkinson's treatment in perspective. Commentary on Levodopa and dopamine agonists in the treatment of Parkinson's disease by Theodore L. Sourkes and Serge Gauthier;Discoveries in Pharmacology;2023

5. Monoamine Oxidase Inhibitor (MAO-I)-Mediated Neuroprotection for Treating Parkinson’s Disease;NeuroPsychopharmacotherapy;2022